Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 652

• Price / Volume Information    Yesterday's Closing Price: $32.30 Daily Weekly Monthly 20 Day Moving Average: 1,268,975 shares Shares Outstanding: 56.26 (millions) Market Capitalization: $1,817.33 (millions) Beta: 1.20 52 Week High: $139.99 52 Week Low: $25.88 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.68% -13.08% 12 Week -39.30% -34.13% Year To Date -58.26% -50.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD. - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - maeve@argotpartners.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer; President and Chair of th James M. Thorburn - Chief Financial Officer Kevin B. Yankton - Chief Accounting Officer William Banyai - Director Nicolas Barthelemy - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/05/22 Share - Related Items Shares Outstanding: 56.26 Most Recent Split Date: (:1) Beta: 1.20 Market Capitalization: $1,817.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.30 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.85 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.90 Price/Cash Flow: - Price / Sales: 11.14 EPS Growth vs. Year Ago Period: -58.97% vs. Previous Quarter: -36.26% Sales Growth vs. Year Ago Period: 54.23% vs. Previous Quarter: 14.54% ROE 03/31/22 - -28.88 12/31/21 - -27.10 09/30/21 - -24.90 ROA 03/31/22 - -23.93 12/31/21 - -22.80 09/30/21 - -21.69 Current Ratio 03/31/22 - 7.85 12/31/21 - 4.81 09/30/21 - 8.67 Quick Ratio 03/31/22 - 7.32 12/31/21 - 4.31 09/30/21 - 8.16 Operating Margin 03/31/22 - -118.64 12/31/21 - -112.70 09/30/21 - -114.93 Net Margin 03/31/22 - -114.96 12/31/21 - -112.70 09/30/21 - -114.93 Pre-Tax Margin 03/31/22 - -122.68 12/31/21 - -121.17 09/30/21 - -116.39 Book Value 03/31/22 - 15.35 12/31/21 - 12.34 09/30/21 - 11.78 Inventory Turnover 03/31/22 - 2.91 12/31/21 - 3.28 09/30/21 - 3.92 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©